Can China’s home-grown mRNA Covid-19 vaccine pass its final tests?

• No serious adverse effects recorded in phase 1 clinical trials but scientists say everything hinges on large-scale study
• China has so far relied on vaccines developed through traditional technology which are less effective against Omicron and Delta